Disclosed are methods for detecting multidrug resistance in neoplastic or damaged cells or multidrug resistant (MDR) neoplastic or damaged cells by detecting an increase in the cell surface expression of vimentin protein in such cells as compared to the level of cell surface expression of vimentin protein in a normal cell or a non-MDR neoplastic cell.
This Application claims the benefit of priority to U.S. Provisional Application No. 60/433,480, filed Dec. 13, 2002, the specification of which is incorporated by reference in its entirety.
